Eros International PLC, a leading global company in the Indian film entertainment industry, announced today that it has priced the U.S. initial public offering of 5,000,000 of its A ordinary shares at $11.00 per share (the “Offering”). The company has granted the underwriters a 30-day option to purchase up to an additional 750,000 A ordinary shares from the company at the initial public offering price to cover over-allotments, if any. The company’s A ordinary shares are expected to begin trading on November 13, 2013 on the New York Stock Exchange under the symbol “EROS.” Deutsche Bank, BofA Merrill Lynch, UBS Securities LLC, Jefferies LLC and Credit Suisse Securities (USA) LLC are acting as Bookrunners in relation to the Offering. The Offering is being made only by means of a prospectus. Copies of the prospectus relating to the Offering may be obtained from: Deutsche Bank Securities Inc., Attn: Prospectus Department, 60 Wall Street, New York, NY 10005, via email at firstname.lastname@example.org, or via telephone at +1 800-503-4611; from BofA Merrill Lynch, Attn: Prospectus Department, 222 Broadway, New York, NY 10038, or via email at email@example.com; from UBS Securities LLC, Attention: Prospectus Department, 299 Park Avenue, New York, NY 10171, or via telephone at +1 888-827-7275; from Jefferies LLC, 520 Madison Avenue, 12th Floor, New York, NY, 10022, Attention: Equity Syndicate Prospectus Department, via telephone at +1 877-547-6340, or via email at Prospectus_Department@Jefferies.com; or from Credit Suisse Securities (USA) LLC, Credit Suisse Prospectus Department, One Madison Avenue, New York, NY 10010. A registration statement and post-effective amendments relating to these securities have been filed with and have become effective or declared effective by the United States Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any state or jurisdiction.